Manitol Hztm

Mannitol, the active ingredient in Manitol Hztm, is an osmotic diuretic presented as a sterile intravenous solution for intravenous use. It creates an osmotic gradient that promotes water excretion and helps lower intracranial and intra‑ocular pressure in acute clinical settings.

GNH USA supplies Manitol Hztm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Mannitol is employed in several clinical situations where rapid osmotic diuresis or pressure reduction is required.

- Intracranial hypertension: reduces cerebral edema and intracranial pressure. - Acute glaucoma: lowers intra‑ocular pressure to preserve vision. - Renal failure with oliguria: increases urine output to aid renal clearance. - Drug intoxication: facilitates elimination of nephrotoxic substances through osmotic diuresis.

Mannitol may cause a range of adverse reactions, from mild to severe, depending on patient factors and dosing.

Common Side Effects: - Headache: mild to moderate pain often related to rapid fluid shifts. - Nausea and vomiting: gastrointestinal upset common with intravenous administration. - Electrolyte disturbances: especially hyponatremia or hypernatremia. - Transient hypotension: due to intravascular volume changes. - Flank pain: related to increased renal flow.

Serious or Rare Side Effects: - Acute renal failure: risk in patients with pre‑existing kidney disease. - Pulmonary edema: fluid overload in susceptible individuals. - Severe electrolyte imbalance: can lead to cardiac arrhythmias. - Allergic reactions: including rash, itching, or anaphylaxis. - Hyperosmolar state: may cause neurological symptoms. - Hemolysis: rare but reported in high‑dose scenarios.

Mannitol requires careful monitoring and specific precautions to ensure safe use.

- Renal function assessment: evaluate baseline creatinine and urine output before initiation. - Fluid balance monitoring: track input and output to avoid overload. - Electrolyte surveillance: check serum sodium, potassium, and osmolality regularly. - Cardiovascular status: monitor blood pressure and heart rate for hypotension. - Contraindications review: avoid in patients with active intracranial bleeding or severe pulmonary edema. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - Loop diuretics (e.g., furosemide): may exacerbate electrolyte loss and renal impairment. - Nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increase risk of acute kidney injury. - Other osmotic agents (e.g., glycerol, hypertonic saline): can cause severe hyperosmolar states.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive blood‑pressure‑lowering effect may require dose adjustment. - Insulin or oral hypoglycemics: osmotic shifts can affect glucose control. - Lithium: altered renal clearance may increase lithium toxicity risk.